mesalamine has been researched along with Methemoglobinemia in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Methemoglobinemia: The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Druez, A | 1 |
Rahier, JF | 1 |
Hébuterne, X | 1 |
Azad Khan, AK | 1 |
Nurazzaman, M | 1 |
Truelove, SC | 1 |
1 trial available for mesalamine and Methemoglobinemia
Article | Year |
---|---|
The effect of the acetylator phenotype on the metabolism of sulphasalazine in man.
Topics: Acetylation; Aminosalicylic Acids; Clinical Trials as Topic; Colitis, Ulcerative; Humans; Mesalamine | 1983 |
1 other study available for mesalamine and Methemoglobinemia
Article | Year |
---|---|
Methaemoglobinaemia and renal failure following mesalazine for treatment of inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Inflammatory Bowel Diseases; Mesalamine; Me | 2014 |